Screening Cardiovascular Patients for Aortic aNeurysms (SCAN)
NCT ID: NCT02179801
Last Updated: 2017-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2014-03-31
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening Cardiovascular Patients for Aortic Aneurysms
NCT01643317
Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease
NCT02086617
Screening of Abdominal Aortic Aneurysms Among Male Patients With TIA Symptoms
NCT01850732
Development of Ultra-Low Dose CT Based Screening for Aortic Aneurysms
NCT03479164
Screening for Thoracic Aortic Aneurysm Among a Cohort of Patients With a Degenerative Abdominal Aortic Aneurysm
NCT01599533
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The SCAN project involves the following elements:
1. Informing the patient with cardiovascular risk factors about the clinical picture of AAA
2. An ultrasound scan of the abdominal aorta in patients with an increased risk for AAA
3. Acquisition of patient data followed by a correlation analysis for the parameters presence of AAA and cardiovascular diseases
The cohort study is part of the SCAN project which is also conducted in an similar way by Catharina Ziekenhuis Eindhoven ClinicalTrials.gov Identifier:NCT01643317.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* at least 1 risk factor for AAA (hypertension, hyperlipidaemia, hyperuricemia, nicotine abuse,positive family history)
Exclusion Criteria
* inability to follow the instructions of the investigator (dementia, lack of time, insufficient understanding of the language)
* insufficient compliance
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I. Medizinischen Klinik und Poliklinik, Technical University of Munich
UNKNOWN
Technical University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Univ.-Prof. Dr. med. Hans-Henning Eckstein
Univ.-Prof. Dr. med. Hans-Henning Eckstein
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hans-Henning Eckstein, Univ.-Prof.Dr.med.
Role: PRINCIPAL_INVESTIGATOR
Department for Vascular and Endovascular Surgery, Klinikum rechts der Isar der Technische Universität München
Karl-Ludwig Laugwitz, Univ.-Prof.Dr.med.
Role: PRINCIPAL_INVESTIGATOR
I. Medizinischen Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinikum rechts der Isar, Klinik und Poliklinik für Vaskuläre und Endovaskuläre Chirurgie
Munich, Bavaria, Germany
I. Medizinischen Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München
München, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GES_SCAN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.